Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma.

Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma. Acta Oncol. 2016 Jan 12;:1-2 Authors: Lee JJ, Chan A, Tang T PMID: 26754959 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26754959?dopt=Abstract

Source: Acta Oncologica - January 12, 2016 Category: Cancer & Oncology Authors: Lee JJ, Chan A, Tang T Tags: Acta Oncol Source Type: research

More News: Cancer & Oncology | Lymphoma | Tuberculosis